In fact, the potential involvement of this cross-communication has also been observed in a meta-analysis, in which the tumors of patients with metastatic ERα-positive/HER2-positive breast cancer relapsed after a short period of TAM treatment compared to patients with HER2-negative cancers [81]. Here, ERBB2 is linked to breast carcinoma.